Endocrine Flashcards

1
Q

Carbimazole

A
  • Thionamide (antithyroid drug)
  • drug of choice
  • prodrug; converted to the active metabolite thiamazole via first pass metabolism
  • has immunosuppressive properties and thus is useful in the treatment of Graves’ disease
  • some serious side effects (agranulocytosis, skin aplasia, rash, nausea, vomiting)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

propiothiouracil (PTU)

A
  • Thionamide (antithyroid drug)
  • Less active and shorter half life than carbimazole so twice the dosing is required.
  • PTU usually second line.
  • reduces the conversion of T4 → T3 peripherally giving some more acute effects.
  • better safety data in pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Propanolol

A
  • beta blocker
  • used for symptomatic treatment in hyperthyroidism
  • do not affect hormone levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Potassium Iodide

A
  • antithyroid drug

- Reduces thyroid hormone release acutely, used in thyroid storm and pre-operatively

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

levothyroxine

A
  • synthetitc T4 used to treat hypothyroidism
  • Generally need 1.7-2.0 micrograms / kg / day (with no gland whatsoever)
  • Best taken on an empty stomach
  • Avoid taking with proton pump inhibitors, ferrous sulphate or calcium
  • Start lower, especially in elderly and in cardiac disease
  • Increased thyroxine increases the load on the heart
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cabergoline

A
  • Dopamine agonist (D2 receptor agonist)
  • treatment of prolactinoma
  • Most commonly used, well tolerated
  • Long half-life, therefore only requires once/twice weekly dosing
  • Also used to treat parkinson’s (but higher doses)
  • Association with cardiac fibrosis
  • Echocardiogram at the start of treatment to determine if there is any fibrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Quinagolide

A
  • Dopamine agonist

- treatment of prolactinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Bromocriptine

A
  • Dopamine agonist

- treatment of prolactinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Thionamides

A

Reduce thyroid hormone synthesis
o Inhibit iodide oxidation
o Inhibit iodination of tyrosine
o Inhibit coupling of iodotyrosines

  • T4 has a long half-life (7 days) and therefore treatment with antithyroid drugs can take from 10-20 days for any clinical benefit to be seen.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hydrocortisone

A
  • cortisol replacement therapy
  • used in adrenal insufficiency
  • treatment is initially empirical, as waiting could be fatal
  • Metabolised to cortisol. Most physiological way of replacing cortisol
  • If unwell, give intravenously first
  • Then 15-30mg oral tablets daily in divided doses (for long-term maintenance)
  • Try to mimic diurnal rhythm
  • Highest levels in the morning, therefore give higher dose in the morning

patient education is important:

  • ‘sick day rules’ – double oral hydrocortisone for 3 days when unwell
  • Cannot stop suddenly, as this will cause adrenal crisis
  • Need to wear identification
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Fludrocortisone

A
  • aldosterone replacement therapy for primary adrenal insufficiency
  • not used for secondary insufficiency because aldosterone is regulated by RAAS, not the pituitary
  • Careful monitoring of BP and plasma potassium to determine the adequacy of replacement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Metyrapone/ketoconazole

A
  • Inhibit cortisol production, but not very well
    tolerated
  • Short term measure for treating cortisol excess
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

spironolactone

A
  • Competitive antagonist at MR, androgen and progesterone receptors
  • Unwanted side effects gynaecomastia, hyperkalaemia
  • Management of Primary Aldosteronism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

eplerenone

A
  • Selective MR antagonist, no observed anti-androgen effects

- Management of Primary Aldosteronism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

amiloride

A
  • blocks ENaC, therefore blocks effect of
    aldosterone
  • Management of Primary Aldosteronism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

PHAEOCHROMOCYTOMA pre-operative treatment

A
  • α1 +/- β1 antagonists to block effects of catecholamine surge
  • Can become haemodynamically unstable in surgery if this is not done
17
Q

fludrocortisone

A
  • aldosterone replacement therapy

- used for primary adrenal insufficiency

18
Q

Hydrocortisone

A
  • cortisol replacement therapy
  • used for primary and secondary adrenal insufficiency
  • Metabolised to cortisol. Most physiological way of replacing cortisol
  • dosing aims to mimic diurnal rhythm
19
Q

Tamsulosin

A
  • alpha 1 antagonist

- causes relaxation of smooth muscle in BPH

20
Q

Treatment of hypercalcaemia

A

1) bisphosphonates - inhibit osteoclasts
2) calcitonin - given as a SC injection, opposes the action of PTH but only effective for 48 hours
3) glucocorticoid therapy - inhibits vitamin D production
4) if primary hyperparathyroidism and resistant to treatment - parathyroidectomy

21
Q

Biguanides

A

Metformin
Mimic action of insulin by suppressing hepatic gluconeogenesis.
Inhibits PEPCK and G6Pase

22
Q

sulphonylureas

A

gliclazide, glipizide, glibenclamide
block ATP-dependent K+ channel, increasing insulin release
May predispose to hypoglycaemia
Associated with weight gain

23
Q

Thiazolidinediones

A

pioglitazone
stimulate expression of genes involved in triglyceride
storage.
o PPARγ agonists
o increase transcription of insulin sensitising genes

Stop inappropriate deposition of lipid in non-adipose tissues (which leads to insulin resistance) – improves insulin sensitivity

Associated with weight gain

24
Q

The incretin effect

A

Observation that more insulin is released when glucose is ingested orally as opposed to injected.

Dependent on incretins - gut hormones that sensitize beta cells to stimulate more insulin release
o Glucagon-like peptide-1 (GLP-1)
o Gastric inhibitory peptide (GIP)

Rapidly inactivated by the enzyme dipeptidyl peptidase-4 (DPP-4).

25
Q

Incretin mimetics

A

Exanatide, Liraglutide
o Mimic incretins (GLP-1)
o Engineered for slower breakdown - not cleaved by DPP-4
o Injected – improve endogenous insulin secretion

associated with weight loss

26
Q

DPP-4 inhibitors

A

sitagliptin, Vildagliptin
o Inhibit DPP-4 - enzyme that breaks down endogenous incretins
o Increase endogenous incretin-mediated increase in insulin secretion
o Oral drugs

27
Q

SGLT2 INHIBITORS

A

Canagliflozin, Dapagliflozin, Empagliflozin

 Inhibit renal re-uptake of glucose from filtrate by SGLT2
 Reduce hyperglycaemia by increased loss of glucose through urine
o NB: makes patients more prone to UTIs

 Marked effect on weight loss (due to calorie loss) and blood pressure (due to osmotic diuresis)
 No risk of hypoglycaemia

28
Q

Which drugs increase insulin release?

A

1) sulphonylureas
2) incretin mimetics
3) DPP-4 inhibitors

29
Q

Which drugs increase insulin sensitivity?

A

1) biguanides

2) thiazolidinediones

30
Q

What are first line drugs for type 2 diabetes?

A

metformin or sulphonylurea

31
Q

What are second line drugs for type 2 diabetes?

A

Metformin therapy and addition of:

sulphonylurea or DPP-4i or thiazolidinedione

32
Q

acarbose

A

inhibits alpha glucosidase, an intestinal enzyme that releases glucose from larger carbohydrates.

33
Q

Orlistat

A

works by inhibiting gastric and pancreatic lipases, the enzymes that break down triglycerides in the intestine

34
Q

Bisphosphonates

A

reduce bone resorption - inhibit osteoclast activity
alendronate
zolendronate

35
Q

Denosumab

A

monoclonal antibody that inhibits RANK ligand which signals to osteoclasts, therefore reduces resorption

36
Q

Teriparatide

A

recombinant parathyroid hormone, binds to osteoblasts to increase bone formation

37
Q

Dexamethasone

A

glucocorticoid action only

38
Q

hydrocortisone

A

1:1 glucocorticoid:mineralocorticoid action

most physiologically similar to cortisol